State Street's 5.1% passive stake is consistent with index fund and institutional ownership patterns. The filing confirms continued institutional interest following CareDx's strong Q3 earnings and raised guidance. Monitor for any future 13G amendments showing accumulation or reduction.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $80.77entry
- T+1 · 6d ago +0.50%α −0.82% · $81.17
- T+4 · todayOpen
- T+5 · in 7h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
State Street Corp filed a new Schedule 13G disclosing a 5.1% passive stake in CareDx as of September 30, 2026, holding 2,623,064 shares. This follows a prior 13G by State Street filed in August 2026, indicating the position was built or crossed the 5% threshold during Q3 2026. The filing is routine for a large index/asset manager and comes shortly after CareDx reported strong Q3 results with revenue up 39% YoY and raised guidance.
Key Financial Metrics
Key Facts
- State Street Corp disclosed beneficial ownership of 2,623,064 shares of CareDx common stock as of September 30, 2026
- The stake represents 5.1% of shares outstanding
- State Street certifies passive intent under Rule 13d-1(b), with no purpose of changing or influencing control
- This is a new 13G filing by State Street; a prior 13G by State Street was filed on August 7, 2026
- State Street is a large bank holding company and asset manager, filing through multiple investment advisor subsidiaries
Financial Impact
Stake valued at approximately $209M based on $4.1B market cap and 5.1% ownership
Risk Factors
- Passive 13G filing; no activist intent or engagement signaled
- Stake size is moderate (5.1%) and typical for a large asset manager
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000093751-26-000627 |
| Document: 0000093751-26-000627-index.html | 0000093751-26-000627 |
| Document: 0000093751-26-000627.txt | 0000093751-26-000627 |
Track record
16 reports on CDNA
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +28.28% at T+60 after the Apr 16, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $77.88 Now $73.72 −5.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $77.88 Now $73.72 −5.34% settles Feb 11
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $81.17 Now $73.72 −9.18% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $80.77 Now $73.72 −8.73% settles Feb 8
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $78.56 Now $73.72 −6.16% settles Feb 4
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $87.41 Now $73.72 −15.66% settles Jan 28
- Oct 29, 202618d ago Institutional Cluster Bearish 4/10 Entry $71.52 Now $73.72 −3.08% settles Jan 27
- Aug 6, 202614w ago Insider Cluster Neutral 3/10 Entry $46.69 to $86.54 Now $73.72 +57.89% ▲ +85.34% +87.47% vs SPY
- Aug 4, 202614w ago 144 Neutral 2/10 Entry $45.50 Now $73.72 +62.02% No price data
- Jul 17, 202617w ago Insider Cluster Neutral 4/10 Entry $39.73 Now $73.72 +85.55% No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers